Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jintrolong in Turner Syndrome Children (Phase II)
CTR20160708Phase 2Completed
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Sep 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of peg-somatropin in Turner syndrome (TS), sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started Sep 2016; status: completed.
02
Drugs
peg-somatropin
03
Conditions
Turner syndrome (TS)
Beyond the preview
Go deeper on CTR20160708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160708.